# MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects

> **NCT01833390** · PHASE2 · COMPLETED · sponsor: **Xemed LLC** · enrollment: 58 (actual)

## Conditions studied

- Asthma
- COPD
- Healthy

## Interventions

- **DRUG:** HXe MRI lung ventilation

## Key facts

- **NCT ID:** NCT01833390
- **Lead sponsor:** Xemed LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2015-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01833390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01833390, "MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01833390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*